Skip to main content

UMSOM Vaccine Expert Highlights Need for Vaccination Among Older Adults During Capitol Hill Briefing

February 23, 2018

Wilbur Chen, MD, MS

An Expanding Population of Older Americans Makes Vaccination a Top Public Health Issue, UMSOM’s Wilbur Chen, MD, MS, Cautions

Today at a briefing on Capitol Hill, Wilbur Chen, MD, MS, Associate Professor of Medicine at the University of Maryland School of Medicine, warned that the U.S. population of adults 65 and older is expected to rise significantly over the next few decades, making vaccinations against diseases like influenza, pneumonia and shingles for this population very critical.

Citing U.S. government estimates, he said that by 2030, 71 million people in the U.S. will be 65 and older and that number will expand to 90 million by 2050. “As we age, the immune system ages,” Dr. Chen said during a briefing hosted by the Alliance for Health Policy on “Healthy Aging and Immunizations.”

Dr. Chen --Chief of the Adult Clinical Studies section at UMSOM’s Center for Vaccine Development (CVD) and Director of the University of Maryland Travel Medicine Practice-- noted that there are several vaccines designed for the aging population for diseases such as influenza, pneumococcus, shingles and tetanus.

Older Americans, he said, accounted for roughly 90% of deaths from influenza each year. Dr. Chen also mentioned that vaccination rates for influenza, pneumococcus, and shingles remain low and are an area of needed improvement.

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Tuesday, December 10, 2019

    UMSOM Researchers to Test Vaccine Designed to Protect Against Serious Illness from Contaminated Food and Water

    Each year, millions of people contract serious diarrheal illnesses typically from contaminated food and water. Among the biggest causes of diarrheal diseases are the bacteria Shigella and enterotoxigenic Escherichia coli (ETEC), and researchers at the University of Maryland School of Medicine are testing a vaccine designed to offer protection against these serious pathogens.


    Tuesday, March 20, 2018

    UMSOM Vaccine Experts Lead Trial on Avian Flu Vaccine

    Vaccine experts at the University of Maryland School of Medicine (UMSOM) have begun multiple clinical trials of vaccines designed to protect against H7N9, an avian influenza virus that was first reported in humans in 2013 in China.